Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 974 of 1,261

  1. US 7879798

    Composition for indolent wound healing and methods of use therefor

    Regenicel, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  2. US 7879810

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  3. US 7879792

    Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  4. US 7879834

    Spiroindoline modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  5. US 7879856

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  6. US 7879874

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  7. US 7879879

    Biphenyl derivatives

    Theravance, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  8. US 7880007

    Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  9. US 7879909

    Use of Treprostinil to treat neuropathic diabetic foot ulcers

    United Therapeutics Corporation · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  10. US 7880010

    Crystalline forms of a dimethylphenyl compound

    Theravance, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  11. US 7879984

    Human antibodies to human CD20 and method of using thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  12. US 7875598

    Compositions useful for the treatment of microbial infections

    The Regents of the University of California · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  13. US 7875711

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  14. US 7875637

    Benzimidazole derivative and use as a II receptor antagonist

    Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  15. US 7875628

    Cyclopamine analogues and methods of use thereof

    Infinity Discovery, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  16. US 7875622

    Methods and compositions for treating pulmonary hypertension and related diseases and disorders

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  17. US 7875629

    Quinolinone compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  18. US 7875450

    Virus-like particles for the induction of autoantibodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  19. US 7875292

    Orally disintegrable tablets

    Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  20. US 7875284

    Methods of manufacturing and modifying taxane coatings for implantable medical devices

    Cook Regentec LLC · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  21. US 7875276

    Urinary tract tissue graft compositions and methods for producing same

    The Board of Regents of the University of Oklahoma · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  22. US 7875262

    Aqueous starch-oil dispersions having improved UV stability and absorbing ability

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  23. US 7875712

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  24. US 7875632

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.